[1] CHENG X, FU QY, ZHENG YL, et al.Telomerase-Active Urine-Derived Stem Cells: Regenerative Solutions for Aging[J]. Ageing Res Rev, 2026, 113: 102939. [2] APETROAEI MM, FRAGKIADAKI P, VELESCU BȘ, et al.Pharmacotherapeutic Considerations on Telomere Biology: the Positive Effect of Pharmacologically Active Substances on Telomere Length[J]. Int J Mol Sci, 2024, 25(14): 7694. [3] AFSHARIf N, Al-GAZALLY ME, RASULOVA I, et al.Sensitive Bioanalytical Methods for Telomerase Activity Detection: a Cancer Biomarker[J]. Anal Methods, 2022, 14(42): 4174-4184. [4] CASADIO V, BRAVACCINI S.Telomerase Activity Analysis in Urine Sediment for Bladder Cancer[J]. Methods Mol Biol, 2021, 2292: 133-141. [5] HE Y, CUI Y, WANG L, et al.Extracellular Vesicles for Delivery of Functional Telomerase[J]. Cell Commun Signal, 2025, 23(1): 509. [6] KHALIFEZADEH M, MASOUMI S, NAJAFI K, et al.Telomerase Biosensors: a Promising Approach in Cancer Diagnostics[J]. Clin Chim Acta, 2026, 579: 120668. [7] CARLUND O, NORBERG A, OSTERMAN P, et al.Telomerase Activity in T-Cells as a Functional Test for Pathogenicity Assessment of Novel Genetic Variants in Telomere Biology Disorders[J]. Sci Rep, 2025, 15(1): 29048. [8] NAKAMURA K.Key Mediators of the Efficacy of Mesenchymal Stem Cells on in vivo Disease Models[J]. Cell Transplant, 2025, 34: 9636897251348566. [9] YAMAGUCHI N, HORIO E, SONODA J, et al.Immortalization of Mesenchymal Stem Cells for Application in Regenerative Medicine and Their Potential Risks of Tumorigenesis[J]. Int J Mol Sci, 2024, 25(24): 13562. [10] HU L, WANG J, ZHOU X, et al.Exosomes Derived from Human Mesenchymal Stem Cells as Nanocarriers for Drug Delivery[J]. J Nanobiotechnology, 2021, 19(1): 107. [11] AFKHAMI H, MAHMOUDVAND G, FAKOURI A, et al.New Insights in Application of Mesenchymal Stem Cells Therapy in Tumor Microenvironment: Pros and Cons[J]. Front Cell Dev Biol, 2023, 11: 1255697. [12] KARAGYAUR M, PRIMAK A, BASALOVA N, et al.Safety and Regenerative Properties of Immortalized Human Mesenchymal Stromal Cell Secretome[J]. Int J Mol Sci, 2025, 26(19): 9322. [13] CHIN SP, SAFFERY NS, THEN KY, et al.Preclinical Assessments of Safety and Tumorigenicity of Very High Doses of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells[J]. In vitro Cell Dev Biol Anim, 2024, 60(3): 307-319. [14] LEONOV GE, GRINCHEVSKAYA LR, MAKHNACH OV, et al.Safety Assessment of Stem Cell-Based Therapies: Current Standards and Advancing Frameworks[J]. Cells, 2025, 14(21): 1660. [15] FÄHNRICH S, WEDEMANN A, STEEBPASS L, et al. Optimized for Routine: Highly Sensitive Fluorescent Telomeric Repeat Ampli-fication Protocol (f-TRAP)[J]. Biotechniques, 2024, 76(10): 517-522. [16] WU X, WU J, DAI J, et al. Aggregation-Induced Emission Luminogens Reveal Cell Cycle-Dependent Telomerase Activity in Cancer Cells[J]. National Science Review, 2021, 8(6): nwaa306. [17] GONZÁLEZ-GUALDA E, BAKER AG, FRUK L, et al. A Guide to Assessing Cellular Senescence in vitro and in vivo[J]. FEBS J, 2021, 288(1): 56-80. [18] ZHANG S, XIONG W, XU S, et al.Recent Advances in DNA Systems for In Situ Telomerase Activity Detection and Imaging[J]. Chemosensors, 2025, 13(1): 17. [19] KARAGYAUR M, PRIMAK A, BASALOVA N, et al.Safety and Regenerative Properties of Immortalized Human Mesenchymal Stromal Cell Secretome[J]. International Journal of Molecular Sciences, 2025, 26(19): 9322. [20] SCHELLNEGGER M, HOFMANN E, CARNIELETTO M, et al.Unlocking Longevity: the Role of Telomeres and Its Targeting Interventions[J]. Front Aging, 2024, 5: 1339317. [21] LI Y, ZHANG F, QINZ, et al. Development of 3D Cell-Based Fluorescent Reporter Assay for Screening of Drugs Downregulating Telomerase Reverse Transcriptase[J]. Bioengineering, 2025, 12(4): 335. [22] MATVEEVA D, KASHIRINA D, EZDAKOVA M, et al.Senescence-Associated Alterations in Matrisome of Mesenchymal Stem Cells[J]. International Journal of Molecular Sciences, 2024, 25(10): 5332. |